E M Kamenskikh
Overview
Explore the profile of E M Kamenskikh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kozlova A, Kamenskikh E, Konovalov R, Chekanova E, Alifirova V, Zakharova M
Zh Nevrol Psikhiatr Im S S Korsakova
. 2024 Aug;
124(7. Vyp. 2):101-108.
PMID: 39175248
Primary central nervous system lymphoma (PCNSL) is a rare neoplasm that can affect the brain, eyes, and, rarely, the spinal cord. Clinical presentation and MRI findings can mimic a variety...
2.
Shaglaeva Y, Titova M, Pashkovskaya D, Kamenskikh E, Alifirova V
Zh Nevrol Psikhiatr Im S S Korsakova
. 2024 Aug;
124(7. Vyp. 2):26-32.
PMID: 39175236
Adherence to therapy largely determines the success of treatment interventions: low levels of adherence are associated with reduced treatment effectiveness. For many chronic diseases, the level of adherence to treatment...
3.
Kamenskikh E, Krygina A, Gomboeva S, Zhailebaeva D, Koval D, Kicherov N, et al.
Zh Nevrol Psikhiatr Im S S Korsakova
. 2024 Aug;
124(7. Vyp. 2):7-15.
PMID: 39175234
Investigation of multiple sclerosis (MS) pathogenesis requires sophisticated analytical tools of precision medicine, such as omics research, which include genomics, microbiomics and metabolomics (proteomics, lipidomics and glycomics). Such sensitive methods...
4.
Kamenskikh E, Alifirova V, Pashkovskaya D, Titova M, Koroleva E, Levchuk L, et al.
Zh Nevrol Psikhiatr Im S S Korsakova
. 2024 Jan;
124(1):89-93.
PMID: 38261289
Objective: To study a role of serum neurofilament light chains (sNFL) in assessment of course and progression of multiple sclerosis (MS) in the population of patients with MS in the...
5.
Alifirova V, Titova M, Kamenskikh E, Shaglaeva I, Pashkovskaya D, Musina N, et al.
Zh Nevrol Psikhiatr Im S S Korsakova
. 2023 Aug;
123(7. Vyp. 2):53-59.
PMID: 37560834
Objective: To investigate a disease-modifying drugs (DMD) response in multiple sclerosis (MS) in the Tomsk region population and detect clinical factors associated with the treatment response. Material And Methods: A...
6.
Kazakov S, Kamenskikh E, Sokolova T, Fedorova O
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med
. 2023 Jul;
31(3):368-378.
PMID: 37427510
Actually, the epidemiology is a dynamically developing medical science located at the intersection of social and biological branches of knowledge and bio-informatics. The new sources of data, the new methods...
7.
Titova M, Alifirova V, Kamenskikh E, Musina N, Nikolaeva T, Paderina D, et al.
Zh Nevrol Psikhiatr Im S S Korsakova
. 2023 Jun;
123(5):160-164.
PMID: 37315256
Objective: To study the effect of the RS6265 polymorphism of gene on the risk of development, main clinical characteristics and DMT response in MS patients in Tomsk region. Material And...
8.
Denisov N, Kamenskikh E, Fedorova O
Sovrem Tekhnologii Med
. 2023 May;
14(4):60-70.
PMID: 37179982
The development of high-throughput technologies has sharply increased the opportunities to research the human body at the molecular, cellular, and organismal levels in the last decade. Rapid progress in biotechnology...
9.
Alifirova V, Kamenskikh E, Koroleva E, Kolokolova E, Petrakovich A
Zh Nevrol Psikhiatr Im S S Korsakova
. 2022 Mar;
122(2):22-27.
PMID: 35271232
Multiple sclerosis (MS) is a chronic autoimmune disease with a high degree of heterogeneity due to course and prognosis. More than half of MS patients do not discuss their long-term...
10.
Alifirova V, Kamenskikh E, Koroleva E
Zh Nevrol Psikhiatr Im S S Korsakova
. 2020 Jan;
119(10. Vyp. 2):7-13.
PMID: 31934983
Pathophysiological processes in multiple sclerosis frequently not diagnosed by clinicians become available for analysis only on the basis of paraclinical data (biomarkers). Nowadays neurofilament light chain can be defined as...